🏆 Deal of the Week · CW 31/2024
osapiens raised EUR 110.7 million in a Series B round; the post-money valuation was not disclosed. The round was co-led by Goldman Sachs Alternatives and existing investor Armira. The close was announced in July 2024 and recognised as Venionaire DealMatrix Deal of the Week for KW 31/2024.
osapiens — key deal facts
| Company | osapiens |
| Founded | 2018 |
| Headquarters | Mannheim, Germany |
| Amount raised | EUR 110.7 M |
| Valuation | Valuation Remains Undisclosed |
| Round | Series B |
| Investors | Goldman Sachs Alternatives, Armira |
| Sectors | Artificial Intelligence (AI), Compliance, SaaS, Software |
Who invested in osapiens?
Goldman Sachs Alternatives and Armira jointly backed the round. The pairing of a global alternative-asset giant with an established European growth-equity backer signals strong institutional conviction in osapiens's regulatory-technology positioning. No additional co-investors have been publicly confirmed.
What does osapiens do?
osapiens, founded in 2018 and headquartered in Mannheim, Germany, develops the osapiens HUB, an AI-powered SaaS platform designed to help companies achieve supply chain transparency, automate ESG and sustainability reporting, and manage product compliance. Core modules address CSRD reporting, Digital Product Passport requirements, product compliance, maintenance operations, and production planning, all underpinned by proprietary AI and IoT engines. The company received the German Founder Award in the Rising Star category in 2022, reflecting early recognition of its growth trajectory.
osapiens valuation & multiples
No existing multiples figures were provided for this deal. Once revenue and EBITDA disclosures become available, the transaction can be benchmarked against prevailing EV/Sales and EV/EBITDA ranges for AI-enabled compliance SaaS peers. Explore Venionaire DealMatrix sector multiples pages for AI, SaaS, and Compliance to place this deal in market context.
Explore the benchmarks: Series B Software.
Frequently asked questions
How much did osapiens raise in its Series B?
osapiens raised EUR 110.7 million in its Series B round, announced in July 2024.
What is osapiens's valuation?
The post-money valuation was not disclosed as part of the Series B announcement.
Who invested in osapiens?
The Series B was backed by Goldman Sachs Alternatives and existing investor Armira.
When was osapiens founded and where is it based?
osapiens was founded in 2018 and is headquartered in Mannheim, Germany.
Source: original announcement — read the full report.